Value of the "Test and Treat" Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of Helicobacter pylori in the Population

Helicobacter

Volumn 21, Issue 3, 2016, Pages 186-191

  Agréus, Lars ^a   Talley, Nicholas J ^b   Jones, Michael ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Dyspepsia diagnosis; Helicobacter pylori; Primary care; Test and treat

Indexed keywords

ARTICLE; DYSPEPSIA; ERADICATION THERAPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HELICOBACTER INFECTION; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADULT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVALENCE;

ANTIINFECTIVE AGENT;

ADULT; ANTI-BACTERIAL AGENTS; DYSPEPSIA; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 84941095583     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12267     Document Type: Article

References (35)

1. Asfeldt AM, Steigen SE, Lochen ML, Straume B, Johnsen R, Bernersen B, Florholmen J, Paulssen EJ. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sorreisa gastrointestinal disorder study. Eur J Epidemiol 2009;24:649-58.
2. Kumagai T, Malaty HM, Graham DY, et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis 1998;178:717-21.
3. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, USA: Lippincott Williams and Wilkins, editor, 2013.
4. Roosendaal R, Kuipers EJ, Buitenwerf J, Van Uffelen C, Meuwissen SG, Van Kamp GJ, Vandenbroucke-Grauls CM. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480-2.
5. Asfeldt AM, Straume B, Steigen SE, Lochen ML, Florholmen J, Bernersen B, Johnsen R, Paulssen EJ. Changes in the prevalence of dyspepsia and Helicobacter pylori infection after 17 years: the Sorreisa gastrointestinal disorder study. Eur J Epidemiol 2008;23:625-33.
6. Okuda M, Miyashiro E, Booka M, Tsuji T, Nakazawa T. Helicobacter pylori Colonization in the First 3 Years of Life in Japanese Children. Helicobacter 2007;12:324-7.
7. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
8. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553-60.
9. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7:887-94.
10. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, Heinonen OP. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
11. Rosenstock S, Jørgensen T, Andersen L, Bonnevie O. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health 2000;54:444-50.
12. Andreasson A, Talley N, Engstrand L, Wallner B, Forsberg A, Hellström PH, Agréus L. The prevalence of Helicobacter pylori positivity in the general population in Sweden has decreased from 38 per cent to 16 per cent since 1989. United European. Gastroenterol J 2014;2(1 Suppl):P0508. [Correction added on 3 November 2015, after first online publication: Reference "Andreasson et al. [12]" was wrongly represented as "Agréus et al. [12] published in the same issue of Helicobacter" and these have been fixed on page 2, 3 and 4 in this current version.]
13. National Institute for Health and Care Excellence (NICE guidelines). Dyspepsia and gastro-oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both: 2014. URL: http://guidance.nice.org.uk/CG/Wave0/609/Consultation/Guidance/pdf/English Accessed: September 2014
14. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80.
15. Ladabaum U, Chey WD, Scheiman JM, Fendrick AM. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. Aliment Pharmacol Ther 2002;16:1491-501.
16. Spiegel BM, Vakil NB, Ofman JJ. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 2002;122:1270-85.
17. Moayyedi P, Axon AT. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999;94:3122-5.
18. Dzierzanowska-Fangrat K, Lehours P, Megraud F, Dzierzanowska D. Diagnosis of Helicobacter pylori infection. Helicobacter 2006;11(Suppl 1):6-13.
19. Buck AA, Gart JJ. Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence. Am J Epidemiol 1966;83:586-92.
20. Gart JJ, Buck AA. Comparison of a screening test and a reference test in epidemiologic studies. II. A probabilistic model for the comparison of diagnostic tests. Am J Epidemiol 1966;83:593-602.
21. Kusters JG, van VA, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.
22. Stael VHC, Agréus L, Engstrand L, et al. Dyspepsia and gastroesophageal reflux disease - a systematic review. The Swedish Council on Technology Assessment in Health Care (SBU); 2007: Report No 185. URL: http://sbu.se/sv/Publicerat/Gul/Dyspepsi-och-reflux-/ ISBN 978-91-85413-17-1
23. Walter SD, Macaskill P, Lord SJ, Irwig L. Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Stat Med 2012;31:1129-38.
24. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2009; 19: CD002096.
25. Agréus L, Lööf L, Norlund A, Engstrand L. Investigation of dyspepsia in Swedish primary health care can become care more effective. Health economic analysis of two management strategies. Läkartidningen 2014;111:1518-20.
26. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 2012;36:3-15.
27. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers after Withdrawal of Therapy. Gastroenterology 2009;9:9.
28. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during Proton Pump Inhibitor therapy. Clin Gastroenterol Hepatol 2010;5:5.
29. Wilhelm SM, Rjater RG, Kale-Pradhan PB. Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol 2013;6:443-51.
30. Larkin CJ, Watson RGP, Sloan JM, Stevenson M, Ardill JE, Buchanan D. Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scand J Gastroenterol 2000;35:578-82.
31. Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter 2009;14:159-71.
32. Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 2003;17:297-305.
33. Gisbert JP, Barrio J, Modolell I, et al. Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy. Dig Dis Sci 2015;60:458-64.
34. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53.
35. Chey WD, Wong BC. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007;102:1808-25.